Back to Authors

Grigoryan, Larissa

Mayo Clinic

Baylor College of Medicine

Citations 2

Clinical Practice Guidelines by Infectious Diseases Society of America 2025 Guidelines on Management and Treatment of Complicated Urinary Tract Infections--Introduction and Methods
Trautner, Barbara W. , Cortés-Penfield, Nicolás , Gupta, Kalpana , Moran, Gregory J. , Colgan, Richard, Ashraf, Muhammad Salman , Connolly, S.J., Grigoryan, Larissa, Nicolle, Lindsay, Schaeffer, A J, Yawetz, Sigal, Lavergne, Valéry , Grigoryan, Larissa , Grigoryan, Larissa , Schaeffer, Anthony , Hirsch, Elizabeth B. , Horstman, Molly J. , O’Horo, John C. , Drekonja, Dimitri Maximilian , Huttner, Angela , Lazenby, Gweneth B. , Nicolle, Lindsay E., Schaeffer, Anthony

Clinical Infectious Diseases | December 11, 2025 | Volume: 82 | Issue: Supplement_3 | Pages: i24-i35

10.1093/cid/ciaf459 Get It

Envisioning Future Urinary Tract Infection Diagnostics
Patel, Robin , Bard, Jennifer Dien , May, Larissa, Lee, Francesca M, Hayden, Mary K. , Doernberg, Sarah D B, Haake, David A. , Grigoryan, Larissa, Tsalik, Ephraim L. , Hanson, Kimberly E. , Grigoryan, Larissa , Patel, Robin , Hanson, Kimberly , Grigoryan, Larissa , Polage, Christopher R. , Fabre, Valeria , Doernberg, Sarah B. , Trautner, Barbara W.

Clinical Infectious Diseases | August 31, 2021 | Volume: 74 | Issue: 7 | Pages: 1284-1292

10.1093/cid/ciab749 Get It

Abstract Urinary tract infections (UTIs) are among the most common bacterial infections in the United States and are a major driver of antibiotic use, both appropriate and inappropriate, across healthcare settings. Novel UTI diagnostics are a strategy that might enable better UTI treatment. Members of the Antibacterial Resistance Leadership Group Laboratory Center and the Infectious Diseases Society of America Diagnostics Committee convened to envision ideal future UTI diagnostics, with a view towards improving delivery of healthcare, patient outcomes and experiences, and antibiotic use, addressing which types of UTI diagnostics are needed and how companies might approach development of novel UTI diagnostics.